CJC-1295 DAC 2mg: What Researchers Need to Know

CJC-1295 DAC 2mg is a 2-milligram vial of a long-acting growth hormone-releasing hormone (GHRH) analog sold for laboratory research. The "DAC" stands for Drug Affinity Complex, a modification that binds the peptide to albumin and extends its half-life to roughly 6 to 8 days in research models. CJC-1295 with DAC is not FDA-approved for human use in the United States, and 2mg refers only to the amount of lyophilized powder in the vial, not a recommended dose.

What CJC-1295 DAC 2mg Is and How It Works

CJC-1295 is a synthetic peptide that mimics the body's own GHRH. It binds to GHRH receptors in the pituitary gland and signals the release of growth hormone (GH). Unlike shorter GHRH analogs, the DAC modification lets the peptide attach to circulating albumin, which slows clearance and keeps it active for days rather than minutes.

The 2mg figure describes the vial's fill weight. A researcher reconstitutes the lyophilized powder with bacteriostatic water or sterile water before use. The resulting concentration depends on how much diluent is added, so a 2mg vial mixed with 2mL of water yields a 1mg/mL solution.

CJC-1295 DAC is studied for its effects on GH and insulin-like growth factor 1 (IGF-1) levels. Published research in healthy adults showed dose-dependent increases in both markers, but these findings come from small, short-term studies and do not establish a safe or effective human dose.

CJC-1295 With DAC vs CJC-1295 Without DAC

The main alternative to CJC-1295 DAC is the shorter peptide known as cjc-1295 without dac. It is also called Mod GRF 1-29 or simply modified GRF. The two peptides share the same core sequence, but the DAC version carries an extra molecular handle that changes its pharmacology.

That difference matters for research design. A peptide with a half-life of a week behaves very differently from one cleared in about 30 minutes. The table below summarizes the practical distinctions.

Researchers sometimes list the short peptide as cjc-1295 no dac; mod grf 1-29 in catalogs to avoid confusion. Neither form is interchangeable with the other in a protocol, because the pharmacokinetics differ so much.

CJC-1295 With DAC Dosage: What Published Research Describes

There is no FDA-approved dosage for CJC-1295 DAC because the peptide is not approved as a drug. Any figure labeled cjc 1295 dac 2mg dosage comes from laboratory research or online discussion, not from a regulatory agency.

In one early clinical study, healthy adults received 30 or 60 mcg/kg of CJC-1295 subcutaneously. IGF-1 levels rose in a dose-dependent manner and stayed elevated for up to six days after a single administration. The study was small and short, so it cannot be used to define a safe or effective regimen.

When researchers discuss cjc-1295 with dac dosage, they usually reference that 30–60 mcg/kg range from the published literature. A 2mg vial contains 2,000 mcg total, so the number of doses per vial depends entirely on body weight and the chosen research amount. None of this information should be read as medical guidance for human use.

Why the Long Half-Life Changes the Math

A peptide that lasts a week accumulates differently than one that clears in half an hour. Repeated injections of a long-acting GHRH analog can raise IGF-1 for extended periods, which is one reason researchers monitor bloodwork closely in controlled settings. Long-term elevations of IGF-1 are a theoretical concern, and the long-term safety of CJC-1295 DAC in humans is unknown.

Storing and Reconstituting a 2mg Vial

Lyophilized CJC-1295 DAC is most stable when kept in a refrigerator at 2–8°C (36–46°F), away from light. The powder should stay dry until it is ready to be reconstituted. Once mixed, most peptide solutions are stored refrigerated and used within a few weeks, though exact stability depends on the diluent and handling.

• Before mixing: Store the sealed vial in the refrigerator, not the freezer, unless the manufacturer specifies otherwise.
• Reconstitution: Add bacteriostatic water or sterile water slowly down the vial wall to avoid foaming.
• After mixing: Keep the solution refrigerated, protect it from light, and avoid repeated freeze-thaw cycles.
• Inspection: Discard any solution that looks cloudy or contains particles.

Always keep research peptides out of reach of children and pets. Do not use a vial that lacks a legible label or a batch number.

Safety, Side Effects, and Legal Status

CJC-1295 with DAC is sold as a research chemical, not as a dietary supplement or prescription drug. The FDA has not approved it for any human condition, and it is illegal to market it as a treatment for weight loss, aging, or athletic performance.

In published trials, reported side effects included injection site reactions, transient flushing, and mild headache. Because those studies were short, the effects of repeated or long-term use are not well characterized. Anyone considering peptide use for health reasons should talk with a licensed healthcare professional instead of relying on forum posts or vendor marketing.

Key conclusion: CJC-1295 DAC is not FDA-approved for human use in the United States, and no safe or effective human dose has been established.

How to Evaluate Quality When Buying CJC-1295 DAC 2mg

A legitimate research supplier should provide a certificate of analysis (COA) for each batch. The COA should include high-performance liquid chromatography (HPLC) purity, mass spectrometry confirmation, and the date of testing. Purity above 98% is a common benchmark in the research peptide market.

A listing labeled cjc 1295 with dac 2mg should also specify cold-chain shipping and a clear storage recommendation. Vials that arrive warm, lack a batch number, or come without third-party testing carry more risk of degraded or misidentified material.

Price alone is a poor quality signal. Extremely cheap vials are sometimes underdosed or contain a different peptide entirely. Reputable vendors publish independent lab results, and some include a QR code that links to the original report.